{
  "emaEpar": [],
  "fdaDrugLabel": [
    {
      "brand": "GUNA-INF ALPHA",
      "indication": "INDICATIONS & USAGE RECURRENT VIRAL INFECTIONS",
      "manufacturer": "Guna spa",
      "splSetId": "f96495b5-1ffe-432c-adcf-b2db9cfd1405"
    }
  ],
  "id": "Recombinant_Interferon_Alfa-2a",
  "nciThesaurus": {
    "casRegistry": "76543-88-9",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A non-glycosylated recombinant human alpha interferon, subtype 2a, produced in the bacterium E. coli.  Interferon alpha-2a binds to its specific cell-surface receptor, resulting in the transcription and translation of genes whose protein products have antiviral, antiproliferative, anticancer, and immune modulating effects.",
    "fdaUniiCode": "47RRR83SK7",
    "identifier": "C1952",
    "preferredName": "Recombinant Interferon Alfa-2a",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [
      "C225"
    ],
    "synonyms": [
      "Alpha 2 Interferon",
      "IFN alpha-2A",
      "IFN-Alpha 2",
      "INTERFERON ALFA-2A",
      "Interferon alfa 2a",
      "Laroferon",
      "Recombinant Interferon Alfa-2a",
      "Recombinant Interferon Alpha-2a",
      "Roceron-A",
      "Roferon A",
      "Roferon-A",
      "rHuIFN-a 2a"
    ]
  }
}